coniferin

CAS No. 531-29-3

coniferin( —— )

Catalog No. M18745 CAS No. 531-29-3

Coniferin has ATP-dependent transport activity and has anti-oxidation effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 222 In Stock
10MG 383 In Stock
25MG 617 In Stock
50MG 872 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    coniferin
  • Note
    Research use only, not for human use.
  • Brief Description
    Coniferin has ATP-dependent transport activity and has anti-oxidation effects.
  • Description
    Coniferin has ATP-dependent transport activity and has anti-oxidation effects. Coniferin has preferred substrates for the coniferin beta-glucosidase, the chromogenic coniferin analogue show the exclusive presence of beta-glucosidase activity in the differentiating xylem, similar to peroxidase activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    531-29-3
  • Formula Weight
    342.34
  • Molecular Formula
    C16H22O8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (292.11 mM)
  • SMILES
    COC1=C(C=CC(=C1)/C=C/CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tsuyama T, et al. Proton-dependent coniferin transport, a common major transport event in differentiating xylem tissue of woody plants.[J]. Plant Physiology, 2013, 162(2):918-926.
molnova catalog
related products
  • Ingenol

    Ingenol mebutate is an effective treatment for actinic keratosis. 2. Formulating novel derivatives from Ingenol esters may be an innovative approach to develop new lead compounds to reactivate latent HIV.

  • Menisperine

    Anti-inflammatory effects (potential NF-κB inhibitors).

  • SJ572403

    SJ572403 is an inhibitor of disordered protein p27.